Tenax Therapeutics (TENX) Preferred Shares (2013 - 2024)

Tenax Therapeutics (TENX) posted quarterly Preferred Shares of $196.0 for Q1 2024, up 19500.0% on a QoQ basis from $1.0 in Q1 2021.

Tenax Therapeutics (TENX) Preferred Shares (2013 - 2024) Analysis & Trends

Tenax Therapeutics has reported Preferred Shares for 5 years, with the latest figure at $196.0 in Q1 2024.

Preferred Shares for Q1 2024 came in at $196.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $196.0 (changed N/A YoY), and the FY2020 annual result was $1262.0, up 31450.0% from the prior year.
Preferred Shares advanced to $196.0 in Q1 2024, from $1.0 in the prior quarter.
Over five years, Preferred Shares peaked at $1262.0 in Q4 2020 and troughed at $1.0 in Q1 2021.
A 3-year average of $486.33 and a median of $196.0 in 2024 frame the typical range for Preferred Shares.
The largest YoY upside for Preferred Shares was 31450.0% in 2020 against a maximum downside of 31450.0% in 2020.
A 3-year view of Preferred Shares shows it stood at $1262.0 in 2020, then slumped by 99.92% to $1.0 in 2021, then soared by 19500.0% to $196.0 in 2024.
Per Business Quant data, the three most recent Preferred Shares figures were $196.0 in Q1 2024, $1.0 in Q1 2021, and $1262.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Tenax Therapeutics	78.47 Mn	78.47 Mn	-	-

Download Data